Ja. Bridge et al., BIOLOGIC AND CLINICAL-SIGNIFICANCE OF CYTOGENETIC AND MOLECULAR CYTOGENETIC ABNORMALITIES IN BENIGN AND MALIGNANT CARTILAGINOUS LESIONS, Cancer genetics and cytogenetics, 69(2), 1993, pp. 79-90
Cartilaginous neoplasms are often histologically and therapeutically c
hallenging. Predicting biologic behavior can be difficult. In this stu
dy, 120 nonneoplastic, benign, and malignant cartilaginous lesions fro
m 103 patients were cytogenetically analyzed in a 6-year period after
short-term culture. For selected cases, fluorescent in situ hybridizat
ion (FISH) techniques using chromosome-specific probes were performed
on metaphase/interphase preparations and on paraffin-embedded tissue s
ections. Clonal abnormalities of chromosomes 2, 3, 5, 7, 8, and 112 we
re most frequently observed. Involvement of chromosomes 5, 8, and 12 m
ay be etiologically significant because of the gene localizations for
the human cartilage link protein, Langer-Giedion syndrome (a rare synd
rome characterized by multiple exostoses), and type II collagen (a maj
or component of normal cartilage) respectively, to these three chromos
omes. That chromosome 7 abnormalities were observed only in malignant
tumors is of diagnostic value. The identity of three marker chromosome
s and the significance of trisomy 7 (a finding of controversial meanin
g), were determined with FISH. That the presence of chromosome aberrat
ions and increasing histologic grade strongly correlated (p = 0.001) i
s of prognostic importance. Moreover, complex aberrations were observe
d nearly exclusively in high-grade tumors (p = 0.001). The data show t
hat nonrandom chromosome loci are aberrantly affected in cartilaginous
lesions and that these abnormalities may be of significant histopatho
genetic consequence. In addition, these chromosome abnormalities appea
r to be diagnostically and prognostically valuable in classifying and
grading chondromatous neoplasms.